These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 1723098

  • 21. Topical levocabastine is more effective than sodium cromoglycate for the prophylaxis and treatment of seasonal allergic conjunctivitis.
    Davies BH, Mullins J.
    Allergy; 1993 Oct; 48(7):519-24. PubMed ID: 7902022
    [Abstract] [Full Text] [Related]

  • 22. Emedastine ophthalmic solution 0.05% versus levocabastine ophthalmic suspension 0.05% in the treatment of allergic conjunctivitis using the conjunctival allergen challenge model.
    Netland PA, Leahy C, Krenzer KL.
    Am J Ophthalmol; 2000 Dec; 130(6):717-23. PubMed ID: 11124289
    [Abstract] [Full Text] [Related]

  • 23. Topical levocabastine protects better than sodium cromoglycate and placebo in conjunctival provocation tests.
    Rimås M, Kjellman NI, Blychert LO, Björkstén B.
    Allergy; 1990 Jan; 45(1):18-21. PubMed ID: 1968726
    [Abstract] [Full Text] [Related]

  • 24. Efficacy of levocabastine hydrochloride ophthalmic suspension in the conjunctival allergen challenge test in Japanese subjects with seasonal allergic conjunctivitis.
    Takamura E, Nomura K, Fujishima H, Fukagawa K, Satake Y, Fukada Y, Sawa M, Uchida E.
    Allergol Int; 2006 Jun; 55(2):157-65. PubMed ID: 17075252
    [Abstract] [Full Text] [Related]

  • 25. The role of levocabastine in the treatment of allergic rhinoconjunctivitis.
    Knight A.
    Br J Clin Pract; 1994 Jun; 48(3):139-43. PubMed ID: 7913336
    [Abstract] [Full Text] [Related]

  • 26. Antiallergic profile of the novel H1-antihistaminic compound levocabastine.
    Tasaka K, Kamei C, Akagi M, Mio M, Shirasaka T, Chokki M.
    Arzneimittelforschung; 1993 Dec; 43(12):1331-7. PubMed ID: 7511378
    [Abstract] [Full Text] [Related]

  • 27. Experimental allergic conjunctivitis in guinea pigs induced by Japanese cedar pollen.
    Takada M, Yamada T, Nakahara H, Sugimoto Y, Izushi K, Kamei C.
    Biol Pharm Bull; 2000 May; 23(5):566-9. PubMed ID: 10823665
    [Abstract] [Full Text] [Related]

  • 28. Selective effect of levocabastine on histamine receptor and histamine release from human leukocytes and guinea pig isolated tissue.
    Garrelds IM, de Graaf-in't Veld T, van Toorenenbergen AW, van Wijk RG, Boegheim JP, Saxena PR, Zijlstra FJ.
    Ann Allergy Asthma Immunol; 1996 Apr; 76(4):327-34. PubMed ID: 8612114
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Inhibitory effect of HSR-6071, a new anti-allergic agent, on experimental asthma in rats and guinea-pigs.
    Makino E, Ohashi T, Takahashi H, Kato H, Ito Y, Nagai H, Koda A, Azuma H.
    J Pharm Pharmacol; 1990 Apr; 42(4):236-41. PubMed ID: 1974289
    [Abstract] [Full Text] [Related]

  • 38. Involvement of chymase in allergic conjunctivitis of guinea pigs.
    Nabe T, Kijitani Y, Kitagawa Y, Sakano E, Ueno T, Fujii M, Nakao S, Sakai M, Takai S.
    Exp Eye Res; 2013 Aug; 113():74-9. PubMed ID: 23726880
    [Abstract] [Full Text] [Related]

  • 39. Clinical evaluation of twice-daily emedastine 0.05% eye drops (Emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis.
    Verin P, Easty DL, Secchi A, Ciprandi G, Partouche P, Nemeth-Wasmer G, Brancato R, Harrisberg CJ, Estivin-Ebrardt C, Coster DJ, Apel AJ, Coroneo MT, Knorr M, Carmichael TR, Kent-Smith BT, Abrantes P, Leonardi A, Cerqueti PM, Modorati G, Martinez M.
    Am J Ophthalmol; 2001 Jun; 131(6):691-8. PubMed ID: 11384563
    [Abstract] [Full Text] [Related]

  • 40. Comparative efficacy of olopatadine 0.1% ophthalmic solution versus levocabastine 0.05% ophthalmic suspension using the conjunctival allergen challenge model.
    Abelson MB, Greiner JV.
    Curr Med Res Opin; 2004 Dec; 20(12):1953-8. PubMed ID: 15701212
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.